Nvwm, LLC Bristol Myers Squibb CO Transaction History

Nvwm, LLC

$382 Million
Q3 2024

A detailed history of Nvwm, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nvwm, LLC holds 32 shares of BMY stock, worth $1,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 22 45.45%

Holding current value

$1,863

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$39.66 - $51.75 $396 - $517	10 Added 45.45%	32 $1,000
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $684 - $900	-17 Reduced 43.59%	22 $0
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $1,871 - $2,121	39 New	39 $2,000
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $10,362 - $11,586	-179 Reduced 64.16%	100 $5,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $616,139 - $684,126	-9,671 Reduced 97.2%	279 $17,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $3,548 - $4,024	-54 Reduced 0.54%	9,950 $689,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $2,054 - $2,432	-30 Reduced 0.3%	10,004 $719,000
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $0 - $230	-3 Reduced 0.03%	10,034 $714,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $721,624 - $794,761	9,937 Added 9937.0%	10,037 $772,000
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $15,370 - $18,430	-250 Reduced 71.43%	100 $7,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $14,426 - $16,817	-269 Reduced 43.46%	350 $18,000
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $5,200 - $5,663	-84 Reduced 11.95%	619 $41,000
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $50,676 - $56,995	-854 Reduced 54.85%	703 $45,000
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $34,586 - $39,192	-599 Reduced 27.78%	1,557 $96,000
Q3 2020 Dec 10, 2020	BUY	$57.43 - $63.64 $34,400 - $38,120	599 Added 38.47%	2,156 $130,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $27,410 - $32,045	-500 Reduced 24.31%	1,557 $92,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $93,449 - $135,804	2,014 Added 4683.72%	2,057 $115,000
Q4 2019 Feb 07, 2020	SELL	$49.21 - $64.19 $28,541 - $37,230	-580 Reduced 93.1%	43 $3,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $315 - $376	-7 Reduced 1.11%	623 $30,000
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $435,719 - $565,023	-8,936 Reduced 93.41%	630 $33,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $499,193 - $563,051	9,045 Added 1736.08%	9,566 $594,000
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $10,156 - $12,658	-201 Reduced 27.84%	521 $29,000
Q1 2018 May 17, 2018	BUY	$59.92 - $68.98 $29,960 - $34,490	500 Added 225.23%	722 $44,000
Q4 2017 Mar 15, 2018	BUY	$59.94 - $65.35 $13,306 - $14,507	222	222 $14,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account